All Stories

  1. Nonproteolytic ubiquitination regulates chromatin occupancy by the NCoR/SMRT/HDAC3 corepressor complex in MCF-7 breast cancer cells
  2. Fasting-mimicking diet counteracts gut microbial dysbiosis in experimental Lynch syndrome
  3. Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells
  4. Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development
  5. TPM4 overexpression drives colon epithelial cell tumorigenesis by suppressing differentiation and promoting proliferation
  6. Modulation of faecal miRNAs highlights the preventive effects of a Mediterranean low-inflammatory dietary intervention
  7. SnoRNA profiling in colorectal cancer and assessment of non-invasive biomarker capacity by ddPCR in fecal samples
  8. Diet-Specific Multi-Omics Markers Associated with Metabolic Health Benefits Can Be Determined in Vegan Population
  9. Small noncoding RNAs and sperm nuclear basic proteins reflect the environmental impact on germ cells
  10. A partial epithelial‐mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction
  11. Tamoxifen Activates Transcription Factor EB and Triggers Protective Autophagy in Breast Cancer Cells by Inducing Lysosomal Calcium Release: A Gateway to the Onset of Endocrine Resistance
  12. Effect of traditional or heat‐not‐burn cigarette smoking on circulating miRNAs in healthy subjects
  13. Profiling small RNAs in fecal immunochemical tests: is it possible?
  14. A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study
  15. Profiling small RNAs in CRC screening samples such as the widely used fecal immunochemical test, is it possible?
  16. Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk
  17. The 8q24 region hosts miRNAs altered in biospecimens of colorectal and bladder cancer patients
  18. DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination
  19. Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas
  20. A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer
  21. Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer
  22. The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells
  23. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma
  24. Faecal miRNA profiles associated with age, sex, BMI, and lifestyle habits in healthy individuals
  25. Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals
  26. Intake of Natural Compounds and Circulating microRNA Expression Levels: Their Relationship Investigated in Healthy Subjects With Different Dietary Habits
  27. Computational Analysis of circRNA Expression Data
  28. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination
  29. Abstract 269: Small non-coding RNA profiling in stool and plasma samples to explore potential biomarkers for colorectal cancer diagnosis
  30. Abstract 257: Whole miRNome profiling in fecal and plasma exosome samples for the diagnosis of colorectal cancer
  31. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
  32. DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage
  33. Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients
  34. Correction for Tarallo et al., “Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples”
  35. Docker4Circ: A Framework for the Reproducible Characterization of circRNAs from RNA-Seq Data
  36. Protocol for a reproducible circRNA analysis using Docker4Circ v4
  37. Author Correction: Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
  38. Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples
  39. Docker4Circ: A Framework for a Reproducible Characterization of CircRNAs from RNA-Seq Data
  40. Protocol for a reproducible circRNA analysis using Docker4Circ v3
  41. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
  42. Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers
  43. MethylFASTQ: A Tool Simulating Bisulfite Sequencing Data
  44. Protocol for a reproducible circRNA analysis using Docker4Circ v2
  45. Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis
  46. Protocol for a reproducible circRNA analysis using Docker4Circ v1
  47. The expression of LINE1-MET chimeric transcript identifies a subgroup of aggressive breast cancers
  48. Reproducible bioinformatics project: a community for reproducible bioinformatics analysis pipelines
  49. Abstract 2761: Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy
  50. ParallNormal: An Efficient Variant Calling Pipeline for Unmatched Sequencing Data
  51. Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis
  52. Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells
  53. Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: description of the diverse and most represented species
  54. Dissecting the genomic activity of a transcriptional regulator by the integrative analysis of omics data
  55. Abstract LB-330: Stool and plasma miRNA profiles by next-generation sequencing: a study on subjects with colorectal cancer and precancerous lesions
  56. Abstract 4431: Urine microRNA profiling in bladder cancer by next-generation sequencing
  57. Next-generation sequencing for miRNA profiling of stool and plasma samples of patients with colorectal cancer or precancerous lesions
  58. Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis
  59. Biologic Data of Cynomolgus Monkeys Maintained under Laboratory Conditions
  60. E2 Regulates Epigenetic Signature on Neuroglobin Enhancer-Promoter in Neuronal Cells
  61. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer
  62. Abstract LB-188: Epigenome-wide study in prediagnostic samples from the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort: Differentially methylated microRNAs in subjects who developed breast cancer
  63. Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort
  64. Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells
  65. Sequence Alignment Tools: One Parallel Pattern to Rule Them All?
  66. Genomic lens on neuroglobin transcription